Candidate genes, pathways and mechanisms for bipolar (manic–depressive) and related disorders: an expanded convergent functional genomics approach

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecular Psychiatry

• Publication date

  2004-11-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1038/sj.mp.4001547PMID 15314610
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Quantitative Study

  2005cited by this paper
• Diverse psychotomimetics act through a common signaling pathway.

  2004cited by this paper
• St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response

  2004cited by this paper
• Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders

  2004cited by this paper
• Cholecystokinin antagonists a new way to improve the analgesia from old analgesics?

  2004cited by this paper
• Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia

  2004cited by this paper
• The molecular genetics of schizophrenia: new findings promise new insights

  2004cited by this paper
• Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients

  2004cited by this paper
• Genomics. Microarrays--guilt by association.

  2003cited by this paper
• An N-terminal fragment of ProSAAS (a granin-like neuroendocrine peptide precursor) is associated with tau inclusions in Pick's disease.

  2003cited by this paper
• Genome wide scan using homozygosity mapping and linkage analyses of a single pedigree with affective disorder suggests oligogenic inheritance

  2003cited by this paper
• What Are the Right Targets for Psychopharmacology?

  2003cited by this paper
• Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

  2003cited by this paper
• Attenuated 5‐HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3‐kinase, Akt and mitogen‐activated protein kinase

  2003cited by this paper
• Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia.

  2003cited by this paper
• Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder

  2003cited by this paper
• Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder.

  2003cited by this paper
• Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

  2003cited by this paper
• Evidence for a putative bipolar disorder locus on 2p13–16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21–24, 13q32, 14q21 and 17q11–12

  2003cited by this paper
• MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients.

  2003cited by this paper
• Characterization of a Neurotrophin Signaling Mechanism that Mediates Neuron Survival in a Temporally Specific Pattern

  2003cited by this paper
• Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis.

  2003cited by this paper
• Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

  2003cited by this paper
• Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system.

  2003cited by this paper
• Genome scan of a second wave of NIMH genetics initiative bipolar pedigrees: chromosomes 2, 11, 13, 14, and X

  2003cited by this paper
• Does Rejection Hurt? An fMRI Study of Social Exclusion

  2003cited by this paper
• Genome scan of the fifty‐six bipolar pedigrees from the NIMH genetics initiative replication sample: Chromosomes 4, 7, 9, 18, 19, 20, and 21

  2003cited by this paper
• Acute and maintenance treatment with mood stabilizers.

  2003cited by this paper
• Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists.

  2003cited by this paper
• Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22.

  2003cited by this paper
• Up‐regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia

  2003cited by this paper
• Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.

  2003cited by this paper
• The association of the D2S2944 124 bp allele with recurrent early onset major depressive disorder in women

  2003cited by this paper
• The Genetics of Adult-Onset Neuropsychiatric Disease: Complexities and Conundra?

  2003cited by this paper
• RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders.

  2003cited by this paper
• Regulation of gene expression and cocaine reward by CREB and DeltaFosB.

  2003cited by this paper
• Cannabis-sensitive dopaminergic markers in postmortem central nervous system: changes in schizophrenia.

  2003cited by this paper
• Glutamate transport, glutamine synthetase and phosphate‐activated glutaminase in rat CNS white matter. A quantitative study

  2003cited by this paper
• Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia.

  2003cited by this paper
• Neuroleukin inhibition sensitises neuronal cells to caspase-dependent apoptosis.

  2003cited by this paper
• Diverse Psychotomimetics Act Through a Common Signaling Pathway

  2003cited by this paper
• Suicide risk and treatments for patients with bipolar disorder.

  2003cited by this paper
• Medicine. What are the right targets for psychopharmacology?

  2003cited by this paper
• Gene Expression Profiles in the Brain Predict Behavior in Individual Honey Bees

  2003cited by this paper
• Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects.

  2003cited by this paper
• Downregulation of Neuronal cdk5/p35 in Opioid Addicts and Opiate-Treated Rats: Relation to Neurofilament Phosphorylation

  2003cited by this paper
• Microarrays--Guilt by Association

  2003influential reference
• Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex

  2003cited by this paper
• Levels of β-secretase BACE and α-secretase ADAM10 mRNAs in Alzheimer hippocampus

  2002cited by this paper
• The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.

  2002cited by this paper
• A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19

  2002cited by this paper
• Substance P and Affective Disorders: New Treatment Opportunities by Neurokinin 1 Receptor Antagonists?

  2002cited by this paper
• 14‐3‐3 Proteins in Lewy Bodies in Parkinson Disease and Diffuse Lewy Body Disease Brains

  2002cited by this paper
• Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia.

  2002cited by this paper
• Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients

  2002cited by this paper
• A linkage disequilibrium study of bipolar disorder and microsatellite markers on 22q13

  2002cited by this paper
• BDNF: a neuromodulator in nociceptive pathways?

  2002cited by this paper
• Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus.

  2002cited by this paper
• Further postmortem autoradiographic studies of AMPA receptor binding in schizophrenia

  2002cited by this paper
• Endophenotypes in bipolar disorder.

  2002cited by this paper
• Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation

  2002cited by this paper
• Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia

  2002cited by this paper
• Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia.

  2002cited by this paper
• A genome-wide scan shows significant linkage between bipolar disorder and chromosome 12q24.3 and suggestive linkage to chromosomes 1p22–21, 4p16, 6q14–22, 10q26 and 16p13.3

  2002cited by this paper
• Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)

  2002cited by this paper
• Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus

  2002cited by this paper
• Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia

  2002cited by this paper
• Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling

  2002cited by this paper
• mRNA and Protein Expression of Selective Alpha Subunits of G Proteins are Abnormal in Prefrontal Cortex of Suicide Victims

  2002cited by this paper
• Finding Genes for Bipolar Disorder in the Functional Genomics Era: From Convergent Functional Genomics to Phenomics and Back

  2002cited by this paper
• Neurokinin-1 receptors are decreased in major depressive disorder

  2002cited by this paper
• Regulation of DARPP‐32 dephosphorylation at PKA‐ and Cdk5‐sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase‐2A

  2002cited by this paper
• Neurobiology of depression.

  2002cited by this paper
• Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia

  2002cited by this paper
• Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex.

  2002cited by this paper
• Manic-depression genes and the new millennium: poised for discovery

  2002cited by this paper
• Neuropeptide Y and its receptors as potential therapeutic drug targets.

  2002cited by this paper
• Diminished Anxiety- and Depression-Related Behaviors in Mice with Selective Deletion of the Tac1 Gene

  2002cited by this paper
• Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor.

  2002cited by this paper
• DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens

  2002cited by this paper
• Association and linkage analyses of RGS4 polymorphisms in schizophrenia.

  2002cited by this paper
• Hyperalgesia during opioid abstinence: mediation by glutamate and substance p.

  2002cited by this paper
• Exploring the opioid system by gene knockout.

  2002cited by this paper
• A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19

  2002cited by this paper
• Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine

  2002cited by this paper
• Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23.

  2001cited by this paper
• Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.

  2001cited by this paper
• A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes

  2001cited by this paper
• Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

  2001cited by this paper
• Increased tachykinin NK(1) receptor immunoreactivity in the prefrontal cortex in schizophrenia.

  2001cited by this paper
• A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q.

  2001cited by this paper
• Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease

  2001cited by this paper
• Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior.

  2001cited by this paper
• Tau protein expression in frontotemporal dementias.

  2001cited by this paper
• Abnormal Kainate Receptor Expression in Prefrontal Cortex in Schizophrenia

  2001cited by this paper
• The human genome: genetic testing and animal models.

  2001cited by this paper
• Neuropeptide Y Y1 and Y2 Receptor mRNA Expression in the Prefrontal Cortex of Psychiatric Subjects

  2001cited by this paper
• N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia.

  2001cited by this paper
• Tbr1 regulates differentiation of the preplate and layer 6.

  2001cited by this paper
• A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22.

  2001cited by this paper

• Exploring hub genes and crucial pathways linked to oxidative stress in bipolar disorder depressive episodes through bioinformatics analysis

  2024cites this paper
• Genome-wide association analysis of treatment resistant schizophrenia for variant discovery and polygenic assessment

  2024cites this paper
• Crosstalk between short- and long-term calorie restriction transcriptomic signatures with anxiety-like behavior, aging, and neurodegeneration: implications for drug repurposing

  2023cites this paper
• Temporal effects on death by suicide: empirical evidence and possible molecular correlates

  2023cites this paper
• CaMKK2 as an emerging treatment target for bipolar disorder

  2023cites this paper
• Decoding frontotemporal and cell-type-specific vulnerabilities to neuropsychiatric disorders and psychoactive drugs

  2022cites this paper
• Evidence of alterations of Beta-endorphin levels and Mu-opioid receptor gene expression in bipolar disorder.

  2022cites this paper
• The Orphan GPCR Receptor, GPR88, Interacts with Nuclear Protein Partners in the Cerebral Cortex.

  2021cites this paper
• Pathological Expression and Circuits in Addiction and Mood Disorders: Informational Relation with the Brain and Info-Therapy

  2021cites this paper
• Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies.

  2021cites this paper
• Alteration in circadian rhythms in bipolar disorder: Mechanisms and implications

  2021cites this paper
• Convergent Functional Genomics approach to prioritize molecular targets of risk in early life stress-related psychiatric disorders

  2020cites this paper
• The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRs

  2020cites this paper
• Orphan G Protein Coupled Receptors in Affective Disorders

  2020influential citation
• Emerging Concepts in Chemical and Biological Sciences

  2020cites this paper
• Pretreatment with GPR88 Agonist Attenuates Postischemic Brain Injury in a Stroke Mouse Model

  2020cites this paper
• Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists.

  2020cites this paper
• Biomarkers of Drug Toxicity and Safety Evaluation

  2019cites this paper
• Prenatal Exposure to Methamphetamine: Up-Regulation of Brain Receptor Genes

  2019cites this paper
• Towards precision medicine for stress disorders: diagnostic biomarkers and targeted drugs

  2019cites this paper
• Cocaine- and amphetamine-regulated transcript (CART): A multifaceted neuropeptide.

  2018cites this paper
• Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target.

  2018cites this paper
• Increased Alcohol Seeking in Mice Lacking Gpr88 Involves Dysfunctional Mesocorticolimbic Networks.

  2018cites this paper
• Neurons derived from patients with bipolar disorder divide into intrinsically different sub-populations of neurons, predicting the patients’ responsiveness to lithium

  2018cites this paper
• Mapping GPR88-Venus illuminates a novel role for GPR88 in sensory processing

  2018cites this paper
• Modeling Strengthens Molecular Link between Circadian Polymorphisms and Major Mood Disorders

  2018cites this paper
• The Gene Encoding Protocadherin 9 (PCDH9), a Novel Risk Factor for Major Depressive Disorder

  2018cites this paper
• GPR88 in A2A receptor‐expressing neurons modulates locomotor response to dopamine agonists but not sensorimotor gating

  2017cites this paper
• Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors

  2017cites this paper
• Methamphetamine Induces TET1- and TET3-Dependent DNA Hydroxymethylation of Crh and Avp Genes in the Rat Nucleus Accumbens

  2017cites this paper
• GPR88 is a critical regulator of feeding and body composition in mice

  2017cites this paper
• Circadian Clock Model Supports Molecular Link Between PER3 and Human Anxiety

  2017cites this paper
• Precision medicine for suicidality: from universality to subtypes and personalization

  2017cites this paper
• Influence of lithium on sleep and chronotypes in remitted patients with bipolar disorder.

  2016cites this paper
• GPR88 in A2AR Neurons Enhances Anxiety-Like Behaviors

  2016cites this paper
• Developmental and adult expression patterns of the G‐protein‐coupled receptor GPR88 in the rat: Establishment of a dual nuclear–cytoplasmic localization

  2016cites this paper
• Mood, stress and longevity: convergence on ANK3

  2016cites this paper
• Effect of Substitution on the Aniline Moiety of the GPR88 Agonist 2-PCCA: Synthesis, Structure-Activity Relationships, and Molecular Modeling Studies.

  2016cites this paper
• A network of synaptic genes associated with schizophrenia and bipolar disorder.

  2016cites this paper
• The Emerging Roles of the Calcineurin-Nuclear Factor of Activated T-Lymphocytes Pathway in Nervous System Functions and Diseases

  2016cites this paper
• Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression

  2016cites this paper
• Candidate gene networks and blood biomarkers of methamphetamine-associated psychosis: an integrative RNA-sequencing report

  2016cites this paper
• Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88.

  2015cites this paper
• White Matter Pathology, Brain Development, and Psychiatric Disorders: Lessons from Corpus Callosum Studies

  2015cites this paper
• Depression-associated ARNTL and PER2 genetic variants in psychotic disorders

  2015cites this paper
• Neurokinin (NK)-1 receptor expression in monocytes from bipolar disorder patients: a pilot study.

  2015cites this paper
• The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.

  2015cites this paper
• Chronobiology of Bipolar Disorder: Therapeutic Implication

  2015cites this paper
• Convergent Lines of Evidence Support LRP8 as a Susceptibility Gene for Psychosis

  2015cites this paper
• Sleep- and circadian rhythm–associated pathways as therapeutic targets in bipolar disorder

  2015cites this paper
• Chronobiological Therapy for Mood Disorders

  2015cites this paper
• Type 2 diabetes mellitus, drug addiction, bipolar disorder and epilepsy display overlapping aetiopathogenic mechanisms: Implication for prevention and pharmacotherapy

  2015cites this paper
• Biomarkers of hippocampal gene expression in a mouse restraint chronic stress model.

  2015cites this paper
• Role of the orphan receptor GPR88 in psychiatric and motor disorders

  2015cites this paper
• Autophosphorylation of CaMKK2 generates autonomous activity that is disrupted by a T85S mutation linked to anxiety and bipolar disorder

  2015cites this paper
• Transcriptomic Analysis of Induced Pluripotent Stem Cells Derived from Patients with Bipolar Disorder from an Old Order Amish Pedigree

  2015cites this paper
• Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene

  2014cites this paper
• Circadian abnormalities in a mouse model of high trait anxiety and depression

  2014cites this paper
• Synthesis, pharmacological characterization, and structure-activity relationship studies of small molecular agonists for the orphan GPR88 receptor.

  2014cites this paper
• Animal Models in Pharmacogenomics

  2014cites this paper
• Biomarkers of drug toxicity

  2014cites this paper
• Title Convergent lines of evidence support CAMKK 2 as a schizophrenia susceptibility gene

  2014cites this paper
• Circadian abnormalities as markers of susceptibility in bipolar disorders.

  2014cites this paper
• Association study in three different populations between the GPR88 gene and major psychoses

  2013influential citation
• fosB-Null Mice Display Impaired Adult Hippocampal Neurogenesis and Spontaneous Epilepsy with Depressive Behavior

  2013cites this paper
• Discovery and validation of blood biomarkers for suicidality

  2013cites this paper
• A large-scale candidate gene analysis of mood disorders: evidence of neurotrophic tyrosine kinase receptor and opioid receptor signaling dysfunction

  2013cites this paper
• Circadian Rhythm Hypotheses of Mixed Features, Antidepressant Treatment Resistance, and Manic Switching in Bipolar Disorder

  2013cites this paper
• Convergent functional genomics of stem cell-derived cells

  2013cites this paper
• Convergent functional genomics of psychiatric disorders

  2013influential citation
• Convergent Functional Genomics of Psychiatric

  2013cites this paper
• Chapter 29 Synaptic and Nuclear Localizations of the G Protein-Coupled Receptor GPR88

  2013cites this paper
• A Comparative Genomic Study in Schizophrenic and in Bipolar Disorder Patients, Based on Microarray Expression Profiling Meta-Analysis

  2013cites this paper
• Depressive Symptoms among Cancer Patients in a Philippine Tertiary Hospital: Prevalence, Factors, and Influence on Health-Related Quality of Life

  2013cites this paper
• P2RX7: Expression Responds to Sleep Deprivation and Associates with Rapid Cycling in Bipolar Disorder Type 1

  2012cites this paper
• Systems Biology, Bioinformatics, and Biomarkers in Neuropsychiatry

  2012cites this paper
• A Chemocentric Informatics Approach to Drug Discovery: Identification and Experimental Validation of Selective Estrogen Receptor Modulators as ligands of 5-Hydroxytryptamine-6 Receptors and as Potential Cognition Enhancers

  2012cites this paper
• Reduced Anxiety and Depression-Like Behaviours in the Circadian Period Mutant Mouse Afterhours

  2012cites this paper
• Using genome-wide expression profiling to define gene networks relevant to the study of complex traits: from RNA integrity to network topology.

  2012cites this paper
• A New Mouse Model for Mania Shares Genetic Correlates with Human Bipolar Disorder

  2012cites this paper
• The behavioral activation system and mania.

  2012cites this paper
• Psychiatric pharmacogenomics in pediatric psychopharmacology.

  2012cites this paper
• Myelin Gene Expression: Implications for Alcohol Abuse and Dependence

  2012cites this paper
• Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder.

  2012cites this paper
• Lack of GPR88 enhances medium spiny neuron activity and alters motor- and cue-dependent behaviors

  2012cites this paper
• Gene expression and genetic association in bipolar disorder

  2012cites this paper
• Common genetic variants and gene-expression changes associated with bipolar disorder are over-represented in brain signaling pathway genes.

  2012cites this paper
• DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families

  2012cites this paper
• Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction

  2012cites this paper
• Intra-accumbal administration of shRNAs against CART peptides cause increases in body weight and cocaine-induced locomotor activity in rats.

  2012cites this paper
• Emerging methods in the molecular biology of neuropsychiatric disorders.

  2012cites this paper
• Cirkadiánní rytmy a deprese

  2012cites this paper
• Convergent functional genomic studies of omega-3 fatty acids in stress reactivity, bipolar disorder and alcoholism

  2011cites this paper
• Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms

  2011influential citation
• Combinations of SNPs Related to Signal Transduction in Bipolar Disorder

  2011cites this paper
• Circadian rhythms and treatment implications in depression.

  2011cites this paper
• Transcriptional profiling to identify biomarkers of disease and drug response.

  2011cites this paper
• Identification of blood biomarkers for psychosis using convergent functional genomics

  2011cites this paper
• Understanding bipolar disorder: the epigenetic perspective.

  2011cites this paper
• Body Weight, Obesity and Suicide across the Life Course

  2011cites this paper